A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Clinical trial NCT07619599 · RECRUITING

Trial details

NCT number: NCT07619599
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Lung Non-Small Cell Carcinoma Metastatic Malignant Neoplasm in the Brain Oligoprogressive Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2026-09-14
Primary completion: 2028-12-22
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.